Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure

1 September 2024 (10:00 - 10:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Hironobu Sumiyoshi

Kameda Medical Center, Kamogawa (Japan)

8 More presentations in this session

Presentation thumbnail

Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm

Doctor A. Morena (Pavia, IT)

Abstract Slides Video

Presentation thumbnail

Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes

Doctor P. D'Ambrosio (Fitzroy, AU)

Abstract Slides Video

Presentation thumbnail

Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin

Doctor O. Al-assaf (Dubai, AE)

Abstract Slides Video

Presentation thumbnail

Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure - a matched case-control study

Doctor S. Ali (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction

Mr O. Levi (Beer Sheva, IL)

Abstract Slides Video

Access the full session

Session thumbnail

Clinical and experimental arrhythmia treatments

The Event

Event poster

ESC Congress 2024

1 September 2024 10:00 CET

You may be interested in

Congress Session

Outcomes and strategies in left atrial appendage closure

Congress Presentation

Outcomes of percutaneous left atrial appendage closure in patients on single antiplatelet therapy versus other antithrombotic regimens

Congress Presentation

What is the optimal anticoagulation/antiplatelet strategy following left atrial appendage closure?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources